Skip to search formSkip to main contentSkip to account menu

liraglutide

Known as: N²?-(hexadecanoyl-gamma-glutamyle)-[34-arginine]GLP-1-(7-37)-peptide, Arg34Lys26-(N-?-(?-Glu(N-?-hexadecanoyl)))-GLP-1[7-37], N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide 
A long-acting, fatty acylated glucagon-like peptide-1 (GLP-1) analog administered subcutaneously, with antihyperglycemic activity. Liraglutide's… 
National Institutes of Health

Related topics

Related topics

15 relations
3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]3 ML liraglutide 6 MG/ML Pen Injector [Victoza]Glucagon-Like Peptide 1In Blood

Broader (2)

Hypoglycemic AgentsIncretins

Narrower (5)

IDegLiraNN 2211SaxendaVictoza

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
2017
2017
All-cause mortality in patients with diabetes under glucagon-like peptide-1 agonists: A population-based, open cohort study.
Highly Cited
2017
Highly Cited
2017
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes…
We thank Dr. Garvey for his letter (1) in response to our 2015 Diabetes Care Editors’ Expert Forum on the prevention of type 2… 
Highly Cited
2016
Highly Cited
2016
Pulmonary , gastrointestinal and urogenital pharmacology Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice
Liraglutide, an effective drug for the treatment of diabetes, has been proven to demonstrate anti-inflammatory and… 
2016
2016
EMPA-REG and Other Cardiovascular Outcome Trials of Glucose-lowering Agents: Implications for Future Treatment Strategies in Type 2 Diabetes Mellitus.
Highly Cited
2015
Highly Cited
2015
Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes.
Review
2013
Review
2013
Novel anti-diabetic agents in non-alcoholic fatty liver disease: a mini-review.
Highly Cited
2012
Highly Cited
2012
glucagon-like peptide 1 analog liraglutide reduces TNF-- induced oxidative tress and inflammation in endothelial cells
Objective: Glucagon-like peptide 1 (GLP-1), one of the incretin hormones, has been reported to increase positive inotropic… 
Review
2011
Review
2011
Liraglutide for the treatment of type 2 diabetes.
This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of… 
2009
2009
Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide.
Although insulin independence is maintained in most islet recipients at 1 yr after transplant, extended follow-up has revealed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)